autologous NK cell therapy

Autologous NK cell therapy is an immunotherapeutic approach that uses a patient's own natural killer (NK) cells, which are harvested, activated, and expanded ex vivo before being reinfused back into the patient. This therapy harnesses the body's innate immune system to target and destroy cancer cells and potentially address neurodegenerative diseases. NK cells are uniquely positioned to target tumor cells that evade immune surveillance by down-regulating self-antigen presentation, and recent findings suggest they can even target cancer stem cells. The therapy has shown promise in both solid tumors and hematological malignancies, with demonstrated safety and efficacy in clinical trials.